Possibility to use barycytinib in patients with COVID-19, including for treatment of «cytokine storm»
Until clinical trials of efficacy and safety are obtained, routine use of barycytinib in patients with COVID-19 cannot be recommended.
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Izdatelstvo OKI,
2020-10-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Until clinical trials of efficacy and safety are obtained, routine use of barycytinib in patients with COVID-19 cannot be recommended. |
|---|---|
| Item Description: | 2588-0519 2618-8473 10.37489/2588-0519-2020-S4-11-14 |